News | News By Subject | News by Disease News By Date | Search News

Inflammatory diseases (misc) News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Ablynx (ABLYF) Seals Nanobody R&D Deal Worth $2.8 Billion With Drug Giant Sanofi (SNY)     7/21/2017
AstraZeneca PLC (AZN) Passes Off Another Amgen (AMGN)-Partnered Drug Candidate in $1.5 Billion Deal With Allergan (AGN)     10/4/2016
FDA Clears Amgen (AMGN) Copy of AbbVie (ABBV)'s Blockbuster Humira     9/26/2016
Amgen (AMGN) Cringes as FDA Approves Novartis AG (NVS)'s Anti-Inflammatory Drug Erelzi     8/31/2016
Gilead (GILD) Invests Up to $2 Billion in Galapagos (GLPG.BR)’ Anti-inflammatory Drug     12/18/2015
Roche (RHHBY), Upsher-Smith Laboratories Partner Up to Develop Inflammatory Disease Drug     12/1/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Novartis AG (NVS)'s AIN457 Meets Primary Endpoint In Two Late Stage Studies     10/23/2014
Telormedix' Vesimune Successfully Completes Phase 2 For Carcinoma In Situ Of The Bladder     5/16/2014
AstraZeneca PLC (AZN) Chases Demon Disease Cure, Potential To Be A Blockbuster Drug     2/17/2014
Novartis Pharma AG (NVS) (JOBS) Obtains EU Positive Opinion For New Biologic Drug     7/29/2009
Regeneron Pharmaceuticals, Inc. (REGN) (JOBS) Receives European Medicines Agency Positive Opinion for Marketing Authorization of Rilonacept for the Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)     7/24/2009
US Approves Novartis AG (JOBS) Auto-Inflammatory Drug     6/19/2009

News from Around the Web
Poor Sleep Health Could Contribute To Inflammatory Disease, UCLA Study     7/6/2016
Curcumin May Help Overcome Drug-Resistant Tuberculosis, University of Colorado Study     3/25/2016
Universite Laval Researchers Identify Molecule With Anti-Inflammatory Properties In Maple Syrup     12/23/2015
Worms And Germs Lead To Better Immune Function, Duke University Medical Center Study     4/10/2015
Disruption Of Circadian Rhythms May Contribute To Inflammatory Disease, Rush University Medical Center Study     5/22/2014
Bone Loss Seen Early in Inflammatory Disorders, VU University Medical Center Study     8/18/2010
Disease Genes That Followed The Silk Road Identified, University of Manchester Study     7/20/2010
New Drug Target For Inflammatory Disease Discovered by University of California, Davis (UCD) Researchers     9/25/2008
Key Protein Molecule Linked To Diverse Human Chronic Inflammatory Diseases, Virginia Tech Study     9/17/2008
Caspase-12: McGill University Researcher Finds New Defense Mechanism Against Intestinal Inflammation     3/13/2008
University of Central Florida Researchers Discover A New Protein Family Implicated In Inflammatory Diseases     3/11/2008
Biomarkers for Inflammatory Disease     12/6/2007
New Insights into Inflammation in Osteoarthritis     10/29/2007
Potential New Way of Treating Inflammatory Diseases Identified     9/14/2007
Muscle Cream Caused NYC Teen's Death     6/11/2007

Press Releases
Curis (CRIS) And Aurigene Discovery Technologies Limited Announce CA-170 Program Update Following Data Presented At ESMO 2017     9/11/2017
ContraVir Receives HBV IND Approval For Tenofovir Exalidex (TXL) In The United States     9/11/2017
Boehringer Ingelheim Pharmaceuticals, Inc. Receives FDA Approval For Cyltezo (Adalimumab-Adbm), A Biosimilar To Humira, For The Treatment Of Multiple Chronic Inflammatory Diseases     8/29/2017
IMRALDI, Biogen (BIIB)’s Adalimumab Biosimilar Referencing Humira, Is Approved In The European Union     8/25/2017
Samsung Bioepis First To Obtain European Commission (EC) Approval For A Third Anti-TNF-? Biosimilar With Imraldi (Adalimumab)     8/25/2017
Erelzi (Etanercept), By Sandoz Canada, Is Now Available For Patients In Canada For The Treatment Of Multiple Inflammatory Diseases     8/21/2017
Neovacs Announces FDA Acceptance Of A New IND To Expand In U.S. Ifnalpha Kinoid Clinical Development Program In Dermatomyositis     7/19/2017
TiGenix Provides Regulatory Update On Cx601 EU Marketing Authorization Application Procedure     5/31/2017
Origenis Announces Patent Grants For Lead Small Molecule LRRK2 Inhibitors For Treatment Of Neurodegenerative And Inflammatory Diseases     5/23/2017
Atlantic Healthcare Confirms Alicaforsen Targets TLR-9, Providing A Second Mechanism Of Action To Treat New And Existing Inflammatory Indications     2/28/2017
X-Chem Expands Collaboration With Janssen Biotech (JNJ) In Inflammatory Diseases     2/15/2017
CytoDyn (CYDY)’s Two-Year Update On Its PRO 140 Monotherapy Study In HIV Accepted At CROI 2017     11/16/2016
Momenta (MNTA) And Mylan (MYL) Initiate Phase I Clinical Trial For M834, A Proposed Biosimilar Of ORENCIA (Abatacept)     11/2/2016
Dermira (DERM) Presents Data From DRM01 Phase IIb Clinical Program At Annual Meeting For Dermatologists     10/21/2016
GlycoMimetics, Inc. (GLYC) Announces Publication Of Preclinical Data Showing Drug Candidate GMI-1271 Reduces Inflammatory Responses After Heart Attack     8/16/2016

//-->